High-Dose Versus Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis.

Saved in:
Bibliographic Details
Title: High-Dose Versus Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis.
Authors: Johansen ND; Department of Cardiology (N.D.J., D.M., K.H.J., T.B.-S.), Copenhagen University Hospital-Herlev and Gentofte, Denmark.; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences (N.D.J., D.M., K.H.J., T.B.-S.), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Modin D; Department of Cardiology (N.D.J., D.M., K.H.J., T.B.-S.), Copenhagen University Hospital-Herlev and Gentofte, Denmark.; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences (N.D.J., D.M., K.H.J., T.B.-S.), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Pardo-Seco J; Genetics, Vaccines and Infectious Diseases Research Group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Spain (J.P.-S., C.R.-T.S., F.M.-T.).; Collaborating Centre for Vaccine Safety, World Health Organization, Santiago de Compostela, Spain (J.P.-S., C.R.-T.S., F.M.-T.).; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain (J.P.-S., C.R.-T.S., F.M.-T.).; Genética de Poblaciones en Biomedicina (GenPoB) Research Group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago, andInstituto de Ciencias Forenses (INCIFOR), Universidade de Santiago de Compostela, Spain (J.P.-S.)., Rodriguez-Tenreiro-Sánchez C; Genetics, Vaccines and Infectious Diseases Research Group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Spain (J.P.-S., C.R.-T.S., F.M.-T.).; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain (J.P.-S., C.R.-T.S., F.M.-T.).; Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago and University of Santiago de Compostela, Spain (C.R.-T.S., F.M.-T.)., Loiacono MM; Sanofi, Morristown, NJ (M.M.L., R.v.A., A.C.).; Department of Epidemiology, University of Delaware, Newark (M.M.L.)., Harris RC; Sanofi, Singapore (R.C.H.)., Dufournet M; Sanofi, Lyon, France (M.D.)., van Aalst R; Sanofi, Morristown, NJ (M.M.L., R.v.A., A.C.)., Chit A; Sanofi, Morristown, NJ (M.M.L., R.v.A., A.C.).; Leslie Dan Faculty of Pharmacy, University of Toronto, Canada (A.C.)., Larsen CS; Department of Clinical Medicine-Department of Infectious Diseases, Aarhus University Hospital, Denmark (C.S.L.).; Danske Lægers Vaccinations Service/European LifeCare Group, Søborg, Denmark (C.S.L.)., Larsen L; Department of Infectious Diseases, Odense University Hospital, Denmark (L.L.)., Wiese L; Department of Infectious Diseases, Zealand University Hospital, Roskilde, Denmark (L.W.)., Dalager-Pedersen M; Department of Infectious Diseases (M.D.-P.), Aalborg University Hospital, Denmark.; Department of Clinical Medicine (M.D.-P.), Aalborg University Hospital, Denmark., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (B.L.C., S.D.S.)., Janstrup KH; Department of Cardiology (N.D.J., D.M., K.H.J., T.B.-S.), Copenhagen University Hospital-Herlev and Gentofte, Denmark.; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences (N.D.J., D.M., K.H.J., T.B.-S.), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Duran-Parrondo C; Dirección Xeral de Saúde Pública (C.D.-P., M.P.-S., M.C.-P., S.M.-C.), Consellería de Sanidade, Xunta de Galicia, Spain., Piñeiro-Sotelo M; Dirección Xeral de Saúde Pública (C.D.-P., M.P.-S., M.C.-P., S.M.-C.), Consellería de Sanidade, Xunta de Galicia, Spain., Cribeiro-González M; Dirección Xeral de Recursos Económicos, Servizo Galego de Saúde, Xunta de Galicia, Spain (M.C.-G.)., Conde-Pájaro M; Dirección Xeral de Saúde Pública (C.D.-P., M.P.-S., M.C.-P., S.M.-C.), Consellería de Sanidade, Xunta de Galicia, Spain., Mirás-Carballal S; Dirección Xeral de Saúde Pública (C.D.-P., M.P.-S., M.C.-P., S.M.-C.), Consellería de Sanidade, Xunta de Galicia, Spain., González-Pérez JM; Subdirección de Sistemas y Tecnologías de la Información (J.-M.G.-P.), Consellería de Sanidade, Xunta de Galicia, Spain., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (B.L.C., S.D.S.)., Sivapalan P; Respiratory Medicine Section, Department of Medicine (P.S., J.U.S.J.), Copenhagen University Hospital-Herlev and Gentofte, Denmark.; Department of Clinical Medicine (P.S., J.U.S.J.), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Martel CJ; Statens Serum Institut, Copenhagen, Denmark (C.J.-M.M.)., Jensen JUS; Respiratory Medicine Section, Department of Medicine (P.S., J.U.S.J.), Copenhagen University Hospital-Herlev and Gentofte, Denmark.; Department of Clinical Medicine (P.S., J.U.S.J.), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Martinón-Torres F; Genetics, Vaccines and Infectious Diseases Research Group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Spain (J.P.-S., C.R.-T.S., F.M.-T.).; Collaborating Centre for Vaccine Safety, World Health Organization, Santiago de Compostela, Spain (J.P.-S., C.R.-T.S., F.M.-T.).; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain (J.P.-S., C.R.-T.S., F.M.-T.).; Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago and University of Santiago de Compostela, Spain (C.R.-T.S., F.M.-T.)., Biering-Sørensen T; Department of Cardiology (N.D.J., D.M., K.H.J., T.B.-S.), Copenhagen University Hospital-Herlev and Gentofte, Denmark.; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences (N.D.J., D.M., K.H.J., T.B.-S.), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.; Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Denmark (T.B.-S.).; Steno Diabetes Center Copenhagen, Herlev, Denmark (T.B.-S.).
Corporate Authors: DANFLU-2 Study Group and the GALFLU Trial Team
Source: Circulation [Circulation] 2026 Mar 17; Vol. 153 (11), pp. 798-806. Date of Electronic Publication: 2025 Nov 10.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1524-4539
DOI:10.1161/CIRCULATIONAHA.125.077801